News & Media
Find recent and archived news, press releases, and stories here.

 Neurocentria launches phase 2 trial in stage 2 AD patients focusing on cognition, mood, and sleep (NC010)

Jul 30, 2018

Neurocentria Launches Phase 2b Clinical Trial Testing the Efficacy of MMFS in Stage 3 and 4 Alzheimer’s Disease Patients (NC007b)

Apr 6, 2018

Neurocentria Announces Completion and Positive Top-Line Results of MMFS Trial in Adult ADHD  

Mar 3, 2018

Neurocentria to Present New Data on MMFS in Mild-Moderate Alzheimer’s Disease at Alzheimer’s Association International Conference (AAIC) 2017

Jul 13, 2017

Neurocentria Publishes Article Demonstrating its Candidate Compound MMFS can Improve Brain Age by 9 Years in Older Adults with Mild Cognitive Impairment 

Oct 28, 2015

 Neurocentria Presents Results of Phase 2 Clinical Study of MMFS in Elderly with Mild Cognitive Impairment at Alzheimer’s Association International Conference (AAIC) 2015 

Jul 13, 2015

Neurocentria Demonstrates that Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 

Sep 13, 2014 

Science Daily: Magnesium Supplement helps boost brain power

Feb 2, 2010

WebMD: Magnesium may improve memory 

Jan 27, 2010

MIT News: Magnesium may reverse middle-age memory loss

Dec 1, 2004

Neurocentria, Inc.

1855 Olympic Blvd., Ste. 225 Walnut Creek, CA., U.S.A.  94596

info@neurocentria.com

925-954-4868

2018 Neurocentria, Inc.